Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement
Recruiting
Observational Study
Type 1 Diabetes (T1D)
Islets of Langerhans Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- University Hospital, Montpellier · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Islet transplantation and pancreas transplantation are established therapeutic options for selected individuals with type 1 diabetes experiencing severe glycemic instability and recurrent hypoglycemia. Although these approaches significantly improve glycemic management and quality of life, long-term graft survival remains limited, with a progressive decline in beta-cell function over time.
The cl…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of type 1 diabetes
* Prior beta-cell replacement therapy : islet transplantation or pancreas transplantation
* Islet re-transplantation performed after 2005
* Islet re-transplantation performed after documented beta cell graft failure, defined by und…
Contacts